BXRX
Baudax Bio, Inc. Common Stock
BXRX
BXRX
Delisted
BXRX was delisted on the 15th of November, 2023.
31 hedge funds and large institutions have $4.12M invested in Baudax Bio, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 9 reducing their positions, and 9 closing their positions.
Holders
31
Holders Change
-7
Holders Change %
-18.42%
% of All Funds
0.54%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
7
Reduced
9
Closed
9
Calls
$180K
Puts
–
Net Calls
+$180K
Net Calls Change
-$164K
Top Buyers
1 |
1
Millennium Management
New York
|
$184K |
2 |
2
Geode Capital Management
Boston,
Massachusetts
|
$383K |
3 |
VF
3
Virtu Financial
New York
|
$70K |
4 |
4
UBS Group
Zurich,
Switzerland
|
$36K |
5 |
5
BlackRock
New York
|
$749K |